The MindFrame Capture LP devices use microcatheter-based flow restoration and clot extraction to treat ischaemic strokes.

The low-profile design of the devices provide enhanced access to distal areas and through tortuous anatomies, as well as increased aspiration, both locally and proximally.

The Capture LP devices have been expanded to include a 4mm diameter and shorter length sizes, which can be deployed through catheters as small as 10/14.

MindFrame president and CEO Ken Charhut said the CE mark approval allows physicians to treat a majority of patients with ischaemic stroke by using low-profile technology for efficient navigation and better aspiration.

”MindFrame is committed to developing leading-edge devices that provide improved procedural and clinical outcomes for clinicians and their patients," Charhut said.

To date, MindFrame Capture LP devices are not approved for marketing in the US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.